Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,956 public trials 1,252 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Active, Not Recruiting

Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients

NCT05078866

Conditions
Colonic Diseases, Colorectal Carcinoma, Colorectal Neoplasms, +17 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • University of Puerto Rico San Juan, Puerto Rico
View Trial Details
Active, Not Recruiting

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

NCT05907304

Conditions
Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +34 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Florida Cancer Specialists - St. Petersburg St. Petersburg, Florida, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

NCT04430738

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Biliary Tract Diseases, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Colorado Denver CTO(CTRC) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

The Active After Cancer Trial (AACT)

NCT00548236

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • University of California at San Diego La Jolla, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • New Hampshire Oncology Hematology Concord, New Hampshire, United States
View Trial Details

Related conditions